全文获取类型
收费全文 | 235篇 |
免费 | 13篇 |
专业分类
妇产科学 | 30篇 |
基础医学 | 11篇 |
口腔科学 | 1篇 |
临床医学 | 29篇 |
内科学 | 119篇 |
皮肤病学 | 3篇 |
神经病学 | 5篇 |
外科学 | 27篇 |
预防医学 | 7篇 |
眼科学 | 1篇 |
药学 | 11篇 |
肿瘤学 | 4篇 |
出版年
2023年 | 1篇 |
2021年 | 6篇 |
2020年 | 4篇 |
2019年 | 7篇 |
2018年 | 2篇 |
2017年 | 3篇 |
2016年 | 2篇 |
2015年 | 4篇 |
2014年 | 7篇 |
2013年 | 10篇 |
2012年 | 13篇 |
2011年 | 15篇 |
2010年 | 6篇 |
2009年 | 9篇 |
2008年 | 21篇 |
2007年 | 21篇 |
2006年 | 12篇 |
2005年 | 19篇 |
2004年 | 17篇 |
2003年 | 15篇 |
2002年 | 7篇 |
2001年 | 7篇 |
2000年 | 6篇 |
1999年 | 7篇 |
1996年 | 4篇 |
1995年 | 3篇 |
1994年 | 2篇 |
1993年 | 1篇 |
1992年 | 3篇 |
1991年 | 5篇 |
1990年 | 2篇 |
1987年 | 3篇 |
1985年 | 1篇 |
1980年 | 1篇 |
1977年 | 1篇 |
1974年 | 1篇 |
排序方式: 共有248条查询结果,搜索用时 15 毫秒
1.
A common polymorphism associated with antibiotic-induced cardiac arrhythmia 总被引:41,自引:0,他引:41 下载免费PDF全文
Sesti F Abbott GW Wei J Murray KT Saksena S Schwartz PJ Priori SG Roden DM George AL Goldstein SA 《Proceedings of the National Academy of Sciences of the United States of America》2000,97(19):10613-10618
Drug-induced long QT syndrome (LQTS) is a prevalent disorder of uncertain etiology that predisposes to sudden death. KCNE2 encodes MinK-related peptide 1 (MiRP1), a subunit of the cardiac potassium channel I(Kr) that has been associated previously with inherited LQTS. Here, we examine KCNE2 in 98 patients with drug-induced LQTS, identifying three individuals with sporadic mutations and a patient with sulfamethoxazole-associated LQTS who carried a single-nucleotide polymorphism (SNP) found in approximately 1.6% of the general population. While mutant channels showed diminished potassium flux at baseline and wild-type drug sensitivity, channels with the SNP were normal at baseline but inhibited by sulfamethoxazole at therapeutic levels that did not affect wild-type channels. We conclude that allelic variants of MiRP1 contribute to a significant fraction of cases of drug-induced LQTS through multiple mechanisms and that common sequence variations that increase the risk of life-threatening drug reactions can be clinically silent before drug exposure. 相似文献
2.
Timp3 deficiency in insulin receptor-haploinsufficient mice promotes diabetes and vascular inflammation via increased TNF-alpha 下载免费PDF全文
Federici M Hribal ML Menghini R Kanno H Marchetti V Porzio O Sunnarborg SW Rizza S Serino M Cunsolo V Lauro D Mauriello A Smookler DS Sbraccia P Sesti G Lee DC Khokha R Accili D Lauro R 《The Journal of clinical investigation》2005,115(12):3494-3505
Activation of inflammatory pathways may contribute to the beginning and the progression of both atherosclerosis and type 2 diabetes. Here we report a novel interaction between insulin action and control of inflammation, resulting in glucose intolerance and vascular inflammation and amenable to therapeutic modulation. In insulin receptor heterozygous (Insr+/-) mice, we identified the deficiency of tissue inhibitor of metalloproteinase 3 (Timp3, an inhibitor of both TNF-alpha-converting enzyme [TACE] and MMPs) as a common bond between glucose intolerance and vascular inflammation. Among Insr+/- mice, those that develop diabetes have reduced Timp3 and increased TACE activity. Unchecked TACE activity causes an increase in levels of soluble TNF-alpha, which subsequently promotes diabetes and vascular inflammation. Double heterozygous Insr+/-Timp3+/- mice develop mild hyperglycemia and hyperinsulinemia at 3 months and overt glucose intolerance and hyperinsulinemia at 6 months. A therapeutic role for Timp3/TACE modulation is supported by the observation that pharmacological inhibition of TACE led to marked reduction of hyperglycemia and vascular inflammation in Insr+/- diabetic mice, as well as by the observation of increased insulin sensitivity in Tace+/- mice compared with WT mice. Our results suggest that an interplay between reduced insulin action and unchecked TACE activity promotes diabetes and vascular inflammation. 相似文献
3.
S. Prudente M. Copetti E. Morini C. Mendonca F. Andreozzi M. Chandalia R. Baratta F. Pellegrini L. Mercuri D. Bailetti N. Abate L. Frittitta G. Sesti J.C. Florez A. Doria V. Trischitta 《Nutrition, metabolism, and cardiovascular diseases : NMCD》2013,23(11):1043-1049
Background/AimsThe development of type 2 diabetes (T2D) is influenced both by environmental and by genetic determinants. Obesity is an important risk factor for T2D, mostly mediated by obesity-related insulin resistance. Obesity and insulin resistance are also modulated by the genetic milieu; thus, genes affecting risk of obesity and insulin resistance might also modulate risk of T2D.Recently, 32 loci have been associated with body mass index (BMI) by genome-wide studies, including one locus on chromosome 16p11 containing the SH2B1 gene. Animal studies have suggested that SH2B1 is a physiological enhancer of the insulin receptor and humans with rare deletions or mutations at SH2B1 are obese with a disproportionately high insulin resistance. Thus, the role of SH2B1 in both obesity and insulin resistance makes it a strong candidate for T2D. However, published data on the role of SH2B1 variability on the risk for T2D are conflicting, ranging from no effect at all to a robust association.MethodsThe SH2B1 tag SNP rs4788102 (SNP, single nucleotide polymorphism) was genotyped in 6978 individuals from six studies for abnormal glucose homeostasis (AGH), including impaired fasting glucose, impaired glucose tolerance or T2D, from the GENetics of Type 2 Diabetes in Italy and the United States (GENIUS T2D) consortium. Data from these studies were then meta-analyzed, in a Bayesian fashion, with those from DIAGRAM+ (n = 47,117) and four other published studies (n = 39,448).ResultsVariability at the SH2B1 obesity locus was not associated with AGH either in the GENIUS consortium (overall odds ratio (OR) = 0.96; 0.89–1.04) or in the meta-analysis (OR = 1.01; 0.98–1.05).ConclusionOur data exclude a role for the SH2B1 obesity locus in the modulation of AGH. 相似文献
4.
5.
Donington JS Litle VR Sesti J Colson YL 《The Annals of thoracic surgery》2012,94(2):452-8; discussion 458-9
6.
Aims/hypothesis C-reactive protein (CRP) is associated with insulin resistance and predicts development of type 2 diabetes. However, it is
unknown whether CRP directly affects insulin signalling action. To this aim, we determined the effects of human recombinant
CRP (hrCRP) on insulin signalling involved in glucose transport in L6 myotubes.
Materials and methods L6 myotubes were exposed to endotoxin-free hrCRP and insulin-stimulated activation of signal molecules, glucose uptake and
glycogen synthesis were assessed.
Results We found that hrCRP stimulates both c-Jun N-terminal kinase (JNK) and extracellular signal-regulated kinase (ERK)1/2 activity. These effects were paralleled by a concomitant
increase in IRS-1 phosphorylation at Ser307 and Ser612, respectively. The stimulatory effects of hrCRP on IRS-1 phosphorylation at Ser307 and Ser612 were partially reversed by treatment with specific JNK and ERK1/2 inhibitors, respectively. Exposure of L6 myotubes to hrCRP
reduced insulin-stimulated phosphorylation of IRS-1 at Tyr632, a site essential for engaging p85 subunit of phosphatidylinositol-3 kinase (PI-3K), protein kinase B (Akt) activation and
glycogen synthase kinase-3 (GSK-3) phosphorylation. These events were accompanied by a decrease in insulin-stimulated glucose
transporter (GLUT) 4 translocation to the plasma membrane, glucose uptake and glucose incorporation into glycogen. The inhibitory
effects of hrCRP on insulin signalling and insulin-stimulated GLUT4 translocation were reversed by treatment with JNK inhibitor
I and the mitogen-activated protein kinase inhibitor, PD98059.
Conclusions/interpretation Our data suggest that hrCRP may cause insulin resistance by increasing IRS-1 phosphorylation at Ser307 and Ser612 via JNK and ERK1/2, respectively, leading to impaired insulin-stimulated glucose uptake, GLUT4 translocation, and glycogen
synthesis mediated by the IRS-1/PI-3K/Akt/GSK-3 pathway. 相似文献
7.
Giovannone B Scaldaferri ML Federici M Porzio O Lauro D Fusco A Sbraccia P Borboni P Lauro R Sesti G 《Diabetes/metabolism research and reviews》2000,16(6):434-441
Insulin receptor substrate (IRS) proteins play a central role in maintaining basic cellular functions such as growth and metabolism. They act as an interface between multiple growth factor receptors possessing tyrosine kinase activity, such as the insulin receptor, and a complex network of intracellular signalling molecules containing Src homology 2 (SH2) domains. Four members (IRS-1, IRS-2, IRS-3, IRS-4) of this family have been identified which differ in their subcellular distribution and interaction with SH2 domain proteins. In addition, differential IRS tissue- and developmental-specific expression patterns may contribute to specificity in their signaling potential. 相似文献
8.
Parts of rat lung tissue have been examined by means of a scanning electron microscope after either chemical or physical fixage. Chemical fixage produces retraction on the tissue structures and the alveoles appear of irregular shape. Physical fixage gives the possibility to observe lung morphology without distorsions; details reproduced are in this case very clear and in a shape which appears very close to the original conditions. 相似文献
9.
The Gly-->Arg972 amino acid polymorphism in insulin receptor substrate-1 affects glucose metabolism in skeletal muscle cells 总被引:5,自引:0,他引:5
Hribal ML Federici M Porzio O Lauro D Borboni P Accili D Lauro R Sesti G 《The Journal of clinical endocrinology and metabolism》2000,85(5):2004-2013
Molecular scanning of insulin receptor substrate-1 (IRS-1) revealed several amino acid substitutions. The most common IRS-1 variant, a Gly to Arg972 change, is more prevalent among type 2 diabetic patients. In this study we overexpressed wild-type and Arg972IRS-1 variant in L6 skeletal muscle cells and examined the functional consequences of this polymorphism on insulin metabolic signaling. L6 cells expressing Arg972-IRS-1 (L6-Arg972) showed a decrease in insulin-stimulated IRS-1-associated phosphatidylinositol 3-kinase (PI 3-kinase) activity compared with L6 cells expressing wild-type IRS-1 (L6-WT) as a consequence of decreased binding of p85 subunit of PI 3-kinase to IRS-1. L6-Arg972 exhibited a decrease in both basal and insulin-stimulated glucose transport due to a reduction in the amount of both GLUT1 and GLUT4 translocated to the plasma membrane. Both basal and insulin-stimulated Akt phosphorylations were decreased in L6-Arg972 compared with L6-WT. Basal glycogen synthase kinase-3 (GSK-3) activity was increased in L6-Arg972 compared with L6-WT, and insulin-induced inactivation of GSK-3 was also reduced in L6-Arg972. This change was associated with a significant decrease in insulin-stimulated glucose incorporation into glycogen and glycogen synthase activity in L6-Arg972 compared with L6-WT. These results indicate that the Arg972-IRS-1 polymorphism impairs the ability of insulin to stimulate glucose transport, glucose transporter translocation, and glycogen synthesis by affecting the PI 3-kinase/Akt/GSK-3 signaling pathway. The present data indicate that the polymorphism at codon 972 of IRS-1 may contribute to the in vivo insulin resistance observed in carriers of this variant. 相似文献
10.